IBDEI0FO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6922,0)
 ;;=C44.520^^46^455^1
 ;;^UTILITY(U,$J,358.3,6922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6922,1,3,0)
 ;;=3^SCC Anal Skin
 ;;^UTILITY(U,$J,358.3,6922,1,4,0)
 ;;=4^C44.520
 ;;^UTILITY(U,$J,358.3,6922,2)
 ;;=^5001057
 ;;^UTILITY(U,$J,358.3,6923,0)
 ;;=C44.521^^46^455^2
 ;;^UTILITY(U,$J,358.3,6923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6923,1,3,0)
 ;;=3^SCC Skin Breast
 ;;^UTILITY(U,$J,358.3,6923,1,4,0)
 ;;=4^C44.521
 ;;^UTILITY(U,$J,358.3,6923,2)
 ;;=^5001058
 ;;^UTILITY(U,$J,358.3,6924,0)
 ;;=C44.529^^46^455^9
 ;;^UTILITY(U,$J,358.3,6924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6924,1,3,0)
 ;;=3^SCC Skin Oth Part of Trunk
 ;;^UTILITY(U,$J,358.3,6924,1,4,0)
 ;;=4^C44.529
 ;;^UTILITY(U,$J,358.3,6924,2)
 ;;=^5001059
 ;;^UTILITY(U,$J,358.3,6925,0)
 ;;=C44.622^^46^455^15
 ;;^UTILITY(U,$J,358.3,6925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6925,1,3,0)
 ;;=3^SCC Skin Right Upper Limb
 ;;^UTILITY(U,$J,358.3,6925,1,4,0)
 ;;=4^C44.622
 ;;^UTILITY(U,$J,358.3,6925,2)
 ;;=^5001070
 ;;^UTILITY(U,$J,358.3,6926,0)
 ;;=C44.629^^46^455^6
 ;;^UTILITY(U,$J,358.3,6926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6926,1,3,0)
 ;;=3^SCC Skin Left Upper Limb
 ;;^UTILITY(U,$J,358.3,6926,1,4,0)
 ;;=4^C44.629
 ;;^UTILITY(U,$J,358.3,6926,2)
 ;;=^5001071
 ;;^UTILITY(U,$J,358.3,6927,0)
 ;;=C44.722^^46^455^14
 ;;^UTILITY(U,$J,358.3,6927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6927,1,3,0)
 ;;=3^SCC Skin Right Lower Limb
 ;;^UTILITY(U,$J,358.3,6927,1,4,0)
 ;;=4^C44.722
 ;;^UTILITY(U,$J,358.3,6927,2)
 ;;=^5001082
 ;;^UTILITY(U,$J,358.3,6928,0)
 ;;=C44.729^^46^455^5
 ;;^UTILITY(U,$J,358.3,6928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6928,1,3,0)
 ;;=3^SCC Skin Left Lower Limb
 ;;^UTILITY(U,$J,358.3,6928,1,4,0)
 ;;=4^C44.729
 ;;^UTILITY(U,$J,358.3,6928,2)
 ;;=^5001083
 ;;^UTILITY(U,$J,358.3,6929,0)
 ;;=C44.82^^46^455^10
 ;;^UTILITY(U,$J,358.3,6929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6929,1,3,0)
 ;;=3^SCC Skin Overlapping Sites
 ;;^UTILITY(U,$J,358.3,6929,1,4,0)
 ;;=4^C44.82
 ;;^UTILITY(U,$J,358.3,6929,2)
 ;;=^5001089
 ;;^UTILITY(U,$J,358.3,6930,0)
 ;;=L57.8^^46^455^22
 ;;^UTILITY(U,$J,358.3,6930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6930,1,3,0)
 ;;=3^Skin Changes d/t Chr Exposure to Nonionizing Radiation
 ;;^UTILITY(U,$J,358.3,6930,1,4,0)
 ;;=4^L57.8
 ;;^UTILITY(U,$J,358.3,6930,2)
 ;;=^5009226
 ;;^UTILITY(U,$J,358.3,6931,0)
 ;;=L27.0^^46^455^23
 ;;^UTILITY(U,$J,358.3,6931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6931,1,3,0)
 ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
 ;;^UTILITY(U,$J,358.3,6931,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,6931,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,6932,0)
 ;;=L27.1^^46^455^24
 ;;^UTILITY(U,$J,358.3,6932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6932,1,3,0)
 ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
 ;;^UTILITY(U,$J,358.3,6932,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,6932,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,6933,0)
 ;;=L51.1^^46^455^29
 ;;^UTILITY(U,$J,358.3,6933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6933,1,3,0)
 ;;=3^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,6933,1,4,0)
 ;;=4^L51.1
 ;;^UTILITY(U,$J,358.3,6933,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,6934,0)
 ;;=L51.3^^46^455^30
 ;;^UTILITY(U,$J,358.3,6934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6934,1,3,0)
 ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
 ;;^UTILITY(U,$J,358.3,6934,1,4,0)
 ;;=4^L51.3
 ;;^UTILITY(U,$J,358.3,6934,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,6935,0)
 ;;=Z12.83^^46^455^19
